Our four assay development laboratories are strategically located in Atlanta, Chicago, Edinburgh and Singapore.
Each central lab is fully equipped with state-of-the-art technologies and standardized instrumentation, and staffed by dedicated teams of scientists. You'll find the R&D support you need:
- Expertise in fluid, tissue and cell-based assay development for biomarker testing.
- A robust commitment to developing new and emerging biomarkers, adding approximately 100–150 new assays annually.
- A range of methodologies to address the specific biomarker and assay development demands of your study.
Through Quintiles' own Translational R&D – Oncology Center of Excellence, our experts in biomarker discovery are providing a better understanding of therapeutic targets, molecular signaling, drug biology and patient response. Those insights add significant value as we develop new assays for your trials.
Assay development for novel biomarkers.